Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Midodrine as Novel Treatment of Post-Cardiopulmonary Bypass Vasoplegic Syndrome

NCT04668859 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.

NCT NCT04668859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04668859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Midodrine as Novel Treatment of Post-Cardiopulmonary Bypass Vasoplegic Syndrome
Lead sponsor
Medstar Health Research Institute
Phase
Phase 4
Overall status
Terminated
Start date
July 29, 2016
Completion date
August 8, 2018
Enrollment
10 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

use of midodrine in post-cardiopulmonary bypass vasoplegic syndrome